CXCR3 and lung carcinoma: We found that CD122 and CD279 increased and CD28 and CD183 decreased in the patients with lung cancer (n = 4) compared to that in healthy volunteers (n = 3, whereas N2 was excluded sine PD1 highly expressed, Table S1) (all p < 0.05, Figure 4B).